Sunrest Lifescience Limited (NSE:SUNREST)

Market Cap	157.92M -48.2%
Revenue (ttm)	520.34M +60.6%
Net Income	17.60M
EPS	4.10
Shares Out	4.29M
PE Ratio	8.98
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600
Average Volume	4,480
Open	36.80
Previous Close	36.80
Day's Range	36.80 - 36.80
52-Week Range	29.55 - 68.00
Beta	-0.74
RSI	49.58
Earnings Date	Feb 12, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of dist...

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 210
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUNREST

Financial Performance

In fiscal year 2025, Sunrest Lifescience's revenue was 334.13 million, an increase of 13.33% compared to the previous year's 294.83 million. Earnings were 20.05 million, an increase of 788.48%.